Select Page

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Nuclear Medicine Market. The report analyzes the Nuclear Medicine Market By Product (Therapeutic, Diagnostic), By Diagnostics (SPECT, PET), By Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy) and By Indication (Cardiovascular Disorders, Oncological Disorders, Neurological Disorders, Others). The Nuclear Medicine Market has been analyzed By Region (North America, Europe, Asia Pacific, Rest of the World) and By Country (U.S., Canada, France, Germany, India, China, Japan and Brazil) for the historical period of 2013-2017 and the forecast period of 2018-2023.

Request Sample Report@ https://www.acquiremarketresearch.com/sample-request/386

According to our Analytics research report “Global Nuclear Medicine Market: Analysis By Product Type (Diagnostic, Therapeutic), By Diagnostic Nuclear Medicine Type, By Therapeutic Nuclear Medicine Type, By Indication, By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) – By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, France, Germany, India, China, Japan, Brazil), global market is projected to display a robust growth represented by a CAGR of 10.07% during 2018 -2023.

The indication segment of Oncological disorders has been witnessing growth at a noteworthy rate over the past few years backed by increased prevalence of cancer, presence of technical advance PET and SPECT equipment to perform treatment, rising number of nuclear centers Amongst the regions, North America accounts for the largest regional share in the global nuclear medicine market in 2018.

More Info and TOC @ https://www.acquiremarketresearch.com/industry-reports/global-nuclear-medicine-market-analysis-by-product-type/386/

Key factors driving the robust growth rate of North America region include well developed healthcare infrastructure, favorable regulatory reforms, rising prevalence of chronic ailment such as cardiovascular disorders, neurological disorders etc. in the region.

The report titled Global Nuclear Medicine Market has covered and analyzed the potential of Global Nuclear Medicine and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global nuclear medicine devices market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Request for Discount@ https://www.acquiremarketresearch.com/discount-request/386

Table of Contents

  1. Research Methodology
  2. Executive Summary
  3. Strategic Recommendations
  4. Nuclear Medicine Market Overview
  5. Global Nuclear Medicine : Growth and Forecast

5.1 By Value (2013-2017)

5.2 By Value (2018-2023)

  1. Global Nuclear Medicine Market: By Indication

6.1 Global Nuclear Medicine Market-By Product Type: Breakdown(%)

6.1.1 Global Nuclear Medicine Market Size and Share, By Product Type, 2017

6.1.2 Global Nuclear Medicine Market Size and Share, By Product Type, 2023

6.2 Global Diagnostic Nuclear Medicine Market Overview

6.2.1 By Value (2013-2023)

6.3 Global Therapeutic Nuclear Medicine Market Overview

6.3.1 By Value (2013-2023)

7 Global Nuclear Medicine Market: By Therapeutic Type

7.1 Global Nuclear Medicine Market: By Therapeutic Type : Breakdown(%)

7.1.1 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type , 2017

7.1.2 Global Nuclear Medicine Market Size and Share, Market-By Therapeutic Type ,2023

7.2 Global Beta Emitters Nuclear Medicine Market Overview

7.2.1 By Value (2013-2023)

7.3 Global Alpha Emitters Nuclear Medicine Market Overview

7.3.1 By Value (2013-2023)

7.4 Global Brachytherapy Nuclear Medicine Market Overview

7.4.1 By Value (2013-2023)